Everolimus 10 mg

Product Description

Everolimus, a mTOR inhibitor, is the active component of the oral medicine known as Everolimus 10 mg. Breast cancer, pancreatic neuroendocrine tumours, advanced kidney cancer, and a few types of brain tumours are among the cancers that it is used to treat. Everolimus inhibits the growth of cancer cells by inhibiting mTOR, a protein essential in cell division and growth. The dosage of the oral pills is determined by the patient's health status and reaction to treatment. The most typical adverse reactions include weariness, diarrhoea, dermatitis, and mouth sores. Everolimus 10 mg has been effective in treating certain malignancies, perhaps benefiting patients and leading to better results. During treatment, close medical care is required.

Features of Everolimus 10 mg:

1. Everolimus, a mTOR inhibitor well-known for its potency in the treatment of cancer, is the active ingredient in Everolimus 10 mg.

2. Breast cancer, pancreatic neuroendocrine tumours, advanced kidney cancer, and a few types of brain tumours are among the cancers for which the tablets are particularly prescribed.

3. Everolimus works by inhibiting mTOR, a protein that controls cell growth and division, which prevents the formation of cancer cells.

4. The tablets are administered orally, offering a practical and non-intrusive means of drug delivery.

5. Offering a personalised therapeutic strategy, the dosage of Everolimus is provided based on each patient's unique medical condition and reaction to therapy.

Everolimus 10 mg benefits:

1. Everolimus has shown effectiveness in the treatment of advanced kidney cancer, pancreatic neuroendocrine tumours, breast cancer, and certain types of brain tumours, potentially providing benefits and better outcomes for people with these particular cancers.

2. Everolimus prevents cancer cells from growing and dividing by blocking mTOR, which helps to slow or stop the formation of tumours.

4. Long-Term Disease regulate: Everolimus medication can help patients with these advanced malignancies regulate their condition and live better.

5. Treatment for Non-Cancerous disorders: Everolimus is also used to control tumour growth and lessen symptom load in some non-cancerous disorders, such as Tuberous Sclerosis Complex and Subependymal Giant Cell Astrocytoma.

6. Adjunct to Other Therapies: To improve overall cancer care, everolimus may be used in conjunction with other cancer therapies or drugs.

7. Oral Treatment Option: Everolimus is administered orally, which is more convenient for patients and enables outpatient or at-home care.

8. Everolimus 10 mg tablets are typically well tolerated, with side effects that may be controlled and are frequently offset by the therapeutic advantages.

9. Potential for enhanced Survival: Patients with advanced kidney cancer, pancreatic neuroendocrine tumours, and specific brain tumours may experience enhanced survival after receiving everolimus treatment.

Individual reactions to Everolimus 10 mg may differ, thus careful medical supervision and monitoring are necessary to manage any potential side effects and improve therapy results. Throughout the course of treatment, patients should speak with their medical specialists for personalised counsel and direction.

Everolimus 10 mg Uses:

1. Advanced Kidney Cancer: When other treatments have failed to control advanced kidney cancer (renal cell carcinoma), everolimus is utilised.

2. Pancreatic Neuroendocrine Tumours: Everolimus is prescribed to treat patients with unresectable, locally progressed, or metastatic pancreatic neuroendocrine tumours (PNET).

3. Breast cancer: Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer are treated with everolimus and exemestane.

4. Patients with tuberous sclerosis complex (TSC) who require therapeutic intervention for subependymal giant cell astrocytoma (SEGA) are treated with everolimus.

Everolimus Side Effects 10 mg:

1. Mouth Ulcers: Some people may experience mouth ulcers or sores.

2. Rash or Skin Conditions: Skin rashes, itching, or other conditions involving the skin may happen.

3. Diarrhoea: Diarrhoea is a typical gastrointestinal side effect.

4. Weakness and weariness are possible side effects for patients.

5. Everolimus may make it more likely for you to get infections, such as respiratory and urinary tract infections.

6. Reduced Appetite: Some people may lose weight or have a decreased appetite.

7. Everolimus has the potential to cause metabolic abnormalities like elevated cholesterol or blood sugar levels.

8. Hypertension: Everolimus's adverse effect of elevated blood pressure is possible.

9. Slow Wound Healing: Everolimus may cause a delay in the healing process.

10. Mood Shifts: Some people may go through mood shifts like depression or anxiety.

11. White blood cell, red blood cell, and platelet counts may fall as a result of everolimus, increasing the risk of infection, anaemia, and bleeding.

12. Changes in Liver and Kidney Function: Everolimus may have an impact on liver and kidney health.

Before beginning Everolimus 10 mg medication, it is crucial to discuss potential side effects and risks with a healthcare provider. Throughout therapy, patients should be continuously watched, and any worrying side effects should be immediately reported to the healthcare professional.